We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News   Feb 26, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

Credit: Sarah Cervantes on Unsplash.

 
 
Advertisement
 

RELATED ARTICLES

Linking Biological Molecules to Fatty Acids To Aid Drug Delivery

News

Houston Methodist researchers have designed a platform where a diabetes drug is chemically linked to fatty acids and then packaged in a nanoparticle resistant to the stomach’s gastric acids.

READ MORE

Indigenous American Ancestry May Be Associated With HER2-positive Breast Cancer

News

An increased proportion of Indigenous American ancestry was associated with a greater incidence of HER2-positive breast cancer, according to a new study.

READ MORE

Skin Patch Vaccine Shows Promise in Neutralizing SARS-CoV-2

News

University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE